2 weeks Ago By ABMN Staff
Moolec Science ( NASDAQ:MLEC – Get Free Report ) is one of 673 publicly-traded companies in the “Holding & other investment offices” industry, but how does it compare to its competitors? We will compare Moolec Science to similar companies based on the strength of its profitability, dividends, earnings, valuation, analyst recommendations, risk and institutional ownership. Analyst Recommendations This is a summary of recent ratings and target prices for Moolec Science and its competitors, as reported by MarketBeat. Moolec Science currently has a consensus target price of $6.
00, indicating a potential upside of 585.71%. As a group, “Holding & other investment offices” companies have a potential upside of 54.
43%. Given Moolec Science’s stronger consensus rating and higher probable upside, research analysts plainly believe Moolec Science is more favorable than its competitors. Profitability Volatility and Risk Moolec Science has a beta of -0.
54, meaning that its share price is 154% less volatile than the S&P 500. Comparatively, Moolec Science’s competitors have a beta of 0.03, meaning that their average share price is 97% less volatile than the S&P 500.
Earnings & Valuation This table compares Moolec Science and its competitors gross revenue, earnings per share and valuation. Moolec Science’s competitors have higher revenue and earnings than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Institutional & Insider Ownership 0.1% of Moolec Science shares are owned by institutional investors. Comparatively, 54.
2% of shares of all “Holding & other investment offices” companies are owned by institutional investors. 19.9% of Moolec Science shares are owned by company insiders.
Comparatively, 26.7% of shares of all “Holding & other investment offices” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary Moolec Science competitors beat Moolec Science on 9 of the 12 factors compared. Moolec Science Company Profile ( Get Free Report ) Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product.
It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg. Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.
com's FREE daily email newsletter ..
